HIV prevention trial design in an era of effective pre-exposure prophylaxis.

Cutrell, Amy.Donnell, Deborah.Dunn, David T.Glidden, David V.Grobler, Anna Christina.Hanscom, Brett.Stancil, Britt S.Meyer, Daniel R.Wang, Ronnie.Cuffe, Robert L.2018-03-182018-03-1820172017Cutrell, A., Donnell, D., Dunn, D.T., Glidden, D.V., Grobler, A., Hanscom, B., Stancil, B.S., Meyer, R.D., Wang, R. and Cuffe, R.L. 2017. HIV prevention trial design in an era of effective pre-exposure prophylaxis. HIV clinical trials 18(5-6), 177-188.http://hdl.handle.net/10413/15098CAPRISA, 2017.Abstract available in pdf.enHIV-1.Pre-exposure prophylaxis (PrEP)TDF/FTC.Non-inferiority trials.Tenofovir disoproxil fumarate/emtricitabine.HIV prevention trial design in an era of effective pre-exposure prophylaxis.Peer reviewed journal article